e-learning
resources
Paris 2018
Tuesday, 18.09.2018
The immune response to tuberculosis: development of biomarkers and diagnostic tools
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Features of development of TB infection caused by different doses of MBT
N. Eremeeva (Yerfteriburg, Russian Federation), T. Tyulkova (Yerfteriburg, Russian Federation), L. Lavrechuk (Yerfteriburg, Russian Federation), K. Belousova (Yerfteriburg, Russian Federation), T. Umpeleva (Yerfteriburg, Russian Federation), D. Vakhrusheva (Yerfteriburg, Russian Federation)
Source:
International Congress 2018 – The immune response to tuberculosis: development of biomarkers and diagnostic tools
Session:
The immune response to tuberculosis: development of biomarkers and diagnostic tools
Session type:
Thematic Poster
Number:
4732
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
N. Eremeeva (Yerfteriburg, Russian Federation), T. Tyulkova (Yerfteriburg, Russian Federation), L. Lavrechuk (Yerfteriburg, Russian Federation), K. Belousova (Yerfteriburg, Russian Federation), T. Umpeleva (Yerfteriburg, Russian Federation), D. Vakhrusheva (Yerfteriburg, Russian Federation). Features of development of TB infection caused by different doses of MBT. 4732
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
Identification of high risk factors for development of active tuberculosis in children with latent tuberculosis infections
Source: International Congress 2017 – Clinical challenges in chronic lung diseases
Year: 2017
Treatment of latent tuberculosis infection: completion rates and adverse effects
Source: Eur Respir J 2003; 22: Suppl. 45, 526s
Year: 2003
Intensity of exposure to pulmonary tuberculosis determines risk of tuberculosis infection and disease
Source: Eur Respir J, 51 (1) 1701578; 10.1183/13993003.01578-2017
Year: 2018
The peculiarities of drug susceptibility of M. tuberculosis isolated from patients with late-stage HIV infection
Source: International Congress 2019 – Extra-pulmonary tuberculosis and comorbidities
Year: 2019
Different genetics background of patients with latent tuberculosis infection versus active tuberculosis
Source: International Congress 2017 – Asthma genetics and genomics in patients and populations
Year: 2017
Outcomes of treatment of latent tuberculosis infection in children with two different regimens
Source: Eur Respir J 2006; 28: Suppl. 50, 487s
Year: 2006
Benefit of treatment of latent tuberculosis infection in individual patients
Source: Eur Respir J 2015; 46: 1397-1406
Year: 2015
Benefit of treatment of latent tuberculosis infection in individual patients
Source: Eur Respir J 2016; 47:1594-1595
Year: 2016
Benefit of treatment of latent tuberculosis infection in individual patients
Source: Eur Respir J 2016; 47:1592-1594
Year: 2016
Assessment of risk factors for the formation of polyorgan tuberculosis in children infected with MBT
Source: Virtual Congress 2020 – Different aspects of paediatric viral and bacterial lung infections
Year: 2020
Role of haptogobins genetically determined phenotypes in the development, treatment and prevention pulmonary tuberculosis
Source: Annual Congress 2010 - Prognosis of tuberculosis
Year: 2010
Completion of treatment for latent tuberculosis infection
Source: Annual Congress 2011 - Clinical tuberculosis
Year: 2011
Frequency of development acquired drug resistance in successful treated patients with newly detected pulmonary tuberculosis
Source: Eur Respir J 2002; 20: Suppl. 38, 612s
Year: 2002
Latent tuberculosis infection in a drug treatment centre
Source: Eur Respir J 2002; 20: Suppl. 38, 366s
Year: 2002
Diagnosis and treatment of latent tuberculosis infection
Source: Eur Respir Monogr 2018; 82: 381-398
Year: 2018
Non-cytokine activation immunoprofiling to differentiate treatment status in latent tuberculosis infection
Source: Virtual Congress 2020 – Non-tuberculous mycobacteria and latent tuberculosis infection
Year: 2020
Tuberculosis in children exposed to MTB with different drug resistance patterns
Source: Virtual Congress 2020 – Multidrug-resistant tuberculosis
Year: 2020
Persistent M. tuberculosis infection: experimental model of endogenously re-activated TB
Source: Eur Respir J 2002; 20: Suppl. 38, 582s
Year: 2002
Interactive case presentation 2 : differentiation between active and latent TB infection
Source: Annual Congress 2008 - PG20 - Advances in the diagnosis of Mycobacterium tuberculosis infection: an interactive, case-based course
Year: 2008
Prevalence of CNS lesions in patients with pulmonary tuberculosis and HIV infection
Source: International Congress 2019 – Tuberculosis: from diagnosis to complications
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept